BMI Calculator for Women: Results Explained

A BMI calculator for women is a quick and accessible way to assess whether your weight falls within a healthy range relative to your height. Body mass index is used by the NHS and NICE as a population-level screening tool, helping to identify potential health risks associated with being underweight, overweight or obese. While the same formula applies to both sexes, there are important considerations specific to women, including hormonal changes, ethnicity and life stage. This article explains how BMI is calculated, how to interpret your result, what to do if your BMI falls outside the healthy range, and the key limitations of BMI as a measure of health for women.

What is BMI and how is it calculated for women?

BMI is calculated by dividing weight in kilograms by height in metres squared; the same formula applies to women as to men, with NHS categories ranging from underweight (below 18.5) to obese (30.0 and above). Lower thresholds apply for some ethnic groups.

BMI, or body mass index, is calculated by dividing a person's weight in kilograms by the square of their height in metres, and the same formula applies to women as to men. The result is expressed as a single number, typically falling somewhere between 15 and 40 for most adults. For example, a woman who weighs 70 kg and stands 1.68 m tall would have a BMI of approximately 24.8.

The NHS and NICE use BMI as a population-level screening tool to categorise weight status. The standard adult categories used in the UK are:

• Below 18.5: underweight

• 18.5 to 24.9: healthy weight

• 25.0 to 29.9: overweight

• 30.0 and above: obese (further divided into classes I, II and III)

These thresholds are set out on the NHS healthy weight pages (nhs.uk) and underpin NICE guidance on obesity in adults. It is worth noting that they were largely derived from studies of white European populations.^[3][5] NICE guidance acknowledges that people from South Asian, Chinese, Black African and Black Caribbean backgrounds may face increased health risks at lower BMI values. For these groups, clinicians may apply lower action points, typically around 23.0 for overweight and 27.5 for obesity, as a prompt to assess health risk earlier. These are risk assessment action points rather than universal diagnostic thresholds, and their use should be guided by a healthcare professional.

For women specifically, BMI does not account for the natural variation in body composition across the menstrual cycle, during pregnancy, or through the menopause transition. Pregnancy is a particular consideration: BMI calculators designed for the general adult population are not intended for use during pregnancy, and weight management during pregnancy should always be guided by a midwife or obstetrician. BMI calculators are also intended for adults aged 18 and over; they are not appropriate for children or young people, who require age- and sex-specific growth charts.

How do I use a BMI calculator and what do my results mean?

Enter your weight and height into a BMI calculator to receive a score and weight category; a healthy BMI of 18.5 to 24.9 is associated with lower risk of type 2 diabetes and cardiovascular disease, but results should always be considered alongside waist circumference, medical history and lifestyle factors.

To use a BMI calculator, you need two measurements: your current weight (in kilograms or stones and pounds) and your height (in metres or feet and inches). Most online calculators, including the NHS BMI calculator available at nhs.uk, will convert units automatically and display your result alongside the relevant weight category.

Once you have your result, it is helpful to understand what it does and does not tell you. A BMI in the healthy range (18.5 to 24.9) suggests that your weight is broadly proportionate to your height, which is associated with a lower risk of conditions such as type 2 diabetes, cardiovascular disease and certain cancers.^[1][20] A result in the overweight or obese range is associated with a statistically higher risk of these conditions, while a result below 18.5 is associated with risks including nutritional deficiency, reduced bone density and, in women of reproductive age, disruption to the menstrual cycle. These associations are described in NHS and NICE guidance on healthy weight and obesity.

However, a single BMI figure should be interpreted alongside other information rather than in isolation. Clinicians typically consider:

• Waist circumference, which reflects central (abdominal) fat distribution and carries independent cardiovascular risk

• Waist-to-height ratio, which NICE recommends as a practical adjunct to BMI in adults; a ratio below 0.5 is generally considered lower risk

• Medical history and family history

• Blood pressure, cholesterol and blood glucose results

• Lifestyle factors such as physical activity, diet and smoking status

If you are using a BMI calculator as a starting point for a conversation about your weight or health, it is a reasonable first step, but your GP or a registered healthcare professional is best placed to interpret the result in the context of your overall health. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, for those who wish to explore their options.

What should I do if my BMI is outside the healthy range?

Speak to your GP, who can assess your overall health and recommend support through the NHS tiered weight management model, ranging from lifestyle advice to specialist services or MHRA-authorised medicines such as orlistat, semaglutide or tirzepatide where clinically appropriate.

If your BMI falls outside the healthy range, the most appropriate next step is to speak with your GP, who can assess your overall health and discuss evidence-based options for support. A BMI result on its own is not a diagnosis, and your GP will consider the full clinical picture before recommending any course of action.

For women with a BMI in the overweight or obese range, NHS England and NICE describe a stepped approach to weight management, often referred to as a tiered service model. The tiers below reflect the NHS commissioning framework; local availability and referral criteria vary by Integrated Care Board (ICB):

• Tier 1: Lifestyle advice, including dietary changes and increased physical activity, often delivered through NHS weight management programmes or referral to community services

• Tier 2: Structured behavioural weight management programmes, which may be available through your local ICB

• Tier 3: Specialist weight management services, which may include pharmacological treatment where clinically appropriate

• Tier 4: Bariatric surgery, considered for people with severe obesity who have not responded to other interventions

Medicines licensed in the UK for chronic weight management include orlistat (available as a generic and as Xenical), semaglutide (Wegovy) and tirzepatide (Mounjaro), all of which are MHRA-authorised. Orforglipron (Foundayo) has also received MHRA authorisation for weight management.^[19] Semaglutide and tirzepatide are subject to NICE technology appraisals.^[9][10] Eligibility criteria apply to all these medicines, and NHS availability depends on local ICB commissioning decisions and service capacity. These medicines are not suitable for everyone, and a prescriber must assess individual suitability before any treatment is started.

For women with a BMI below 18.5, your GP may refer you to a dietitian or, where an eating disorder is suspected, to a specialist service. If you are concerned about your weight or your relationship with food, contacting your GP is the right first step rather than attempting to manage this independently.

Is BMI an accurate measure of healthy weight for women?

BMI is a practical screening tool but cannot distinguish fat mass from lean mass, and its accuracy for women is affected by hormonal changes, age and ethnicity; waist circumference and waist-to-height ratio are recommended as complementary measures.

BMI is a useful population-level screening tool, but it has well-recognised limitations as an individual measure of health for women, and clinicians and researchers have debated its accuracy for decades. The core limitation is that BMI measures overall body mass relative to height but cannot distinguish between fat mass and lean mass (muscle, bone and organ tissue). A woman who is physically active and muscular may have a BMI in the overweight range despite having a healthy body fat percentage, while a woman with a normal BMI may carry a disproportionate amount of visceral fat, which carries metabolic risk.

For women specifically, several additional factors affect how BMI should be interpreted:

• Hormonal changes across the lifespan, including puberty, pregnancy, the postnatal period and the menopause transition, alter body composition in ways that BMI does not capture

• Ethnicity, as discussed above, means that standard UK thresholds may underestimate risk in some groups and overestimate it in others

• Age, because older women tend to have a higher proportion of body fat at any given BMI compared with younger women^[22][23]

Alternative or complementary measures include waist circumference and waist-to-height ratio. NICE recommends waist-to-height ratio as a practical adjunct to BMI for adults; a ratio below 0.5 is generally considered lower risk. NHS guidance also uses waist circumference as an indicator of cardiometabolic risk: a measurement at or above 80 cm in women is associated with increased risk, though this threshold may need to be interpreted differently across ethnic groups.^[3][6] DEXA scanning can measure body composition directly but is not routinely used in primary care.

Despite its limitations, BMI remains a practical, low-cost and widely validated tool that is useful when interpreted alongside other clinical information. It is best understood as a starting point for a broader conversation about health rather than a definitive verdict on any individual woman's wellbeing.

Scientific References

1. Overweight and obesity in adults.
2. Calculate your body mass index (BMI) for adults.
3. Overweight and obesity management (NG246) – Identifying and assessing overweight, obesity and central adiposity.
4. Overweight and obesity management (NG246) – Full guideline PDF.
5. Overweight and obesity management (NG246) – Appendix A1: Summary of evidence from surveillance.
6. Keep the size of your waist to less than half of your height – NICE recommends.
7. Calculate your waist to height ratio.
8. Malnutrition.
9. Semaglutide for managing overweight and obesity (TA875).
10. Tirzepatide for managing overweight and obesity (TA1026).
11. Orlistat: a medicine to treat obesity.
12. Orlistat safety update.
13. XENICAL (orlistat) – EPAR product information.
14. MHRA approves GLP-1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults.
15. First GLP-1 tablet for weight loss approved in the UK (semaglutide/Wegovy).
16. Semaglutide – Drugs – BNF/NICE.
17. MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
18. Tirzepatide – Drugs – BNF/NICE.
19. UK first in Europe to authorise orforglipron (Foundayo) for weight management and type 2 diabetes.
20. Health matters: preventing type 2 diabetes.
21. Coin A et al. Bone mineral density and body composition in underweight elderly subjects. Aging Clin Exp Res. 2000..
22. Body mass index for the assessment of adiposity in healthy aging Caucasian women: a dual-energy X-ray absorptiometry based study. Rheumatol Int. 2025..
23. Sarcopenia and Sarcopenic Obesity in Postmenopausal Women: Limitations of BMI as a Predictor of Sarcopenic Obesity. Aging Med. 2025..

Frequently Asked Questions